Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pioglitazone on Sputum Biomarkers of Inflammation and Lung Epithelial Repair in Cystic Fibrosis

NCT00719381 is registered in ClinicalTrials.gov with Paul Beringer as lead sponsor.

NCT NCT00719381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00719381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pioglitazone on Sputum Biomarkers of Inflammation and Lung Epithelial Repair in Cystic Fibrosis
Lead sponsor
Paul Beringer
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2009
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis